Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 10, 2026
Carpenter Technology (CRS) Falls -18.1% in 30 Days Despite Record Earnings

Carpenter Technology (CRS) Falls -18.1% in 30 Days Despite Record Earnings

Key Takeaways

  • Carpenter Technology (CRS) shares fell about 18.1% over the trailing 30 days, from roughly $559.75 on August 10 to $458.45 at the September 9 close, despite record fiscal fourth-quarter results.
  • The decline followed the company's fiscal Q4 2026 report, which beat on earnings per share ($3.23 versus the $3.08 consensus) but posted revenue of $851.0 million, slightly below the $863.3 million estimate.
  • Profit-taking and a stretched valuation weighed on the stock after a run that left it up more than 85% year over year and roughly 46% year to date.
  • A new $1.0 billion share-repurchase authorization announced in August and several analyst price-target increases did not offset the broader selling pressure.
  • Over the trailing quarter, CRS is down about 18%, even as management guided fiscal 2027 operating income to a range of $850 million to $880 million.

Understanding Carpenter Technology's Business and Position

Carpenter Technology Corporation (CRS) is a Philadelphia-based producer of high-performance specialty alloys and process solutions. Founded in 1889, the company supplies nickel, cobalt, and titanium alloys and premium stainless steels used in critical applications across the aerospace and defense, medical, energy, transportation, and industrial and consumer markets. Its Specialty Alloys Operations (SAO) segment generates the bulk of revenue and profit, while its Performance Engineered Products segment supplies titanium materials and powders used in additive manufacturing. Aerospace and defense is by far the largest end market, accounting for roughly 66% of net sales excluding surcharge, which makes CRS a direct play on commercial aircraft build rates and defense spending. Investors follow the stock closely for its exposure to jet-engine, fastener, and structural-component supply chains and for its sustained record of margin expansion. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

CRS Stock Performance Over the Last 30 Days and Quarter

Over the last 30 days, CRS declined approximately 18.1%, from a close near $559.75 on August 10 to $458.45 on September 9. The move pulled shares well below their 50-day moving average, which had been above $550, and erased a meaningful portion of the stock's earlier 2026 gains. Over the trailing three-month period, the shares are down roughly 18.5%, with most of the decline concentrated after the stock set a 52-week high of $625.98 and briefly traded above $619 in early July. In short, the shares rallied into late June and early July, then gave back much of that advance even though year-to-date performance remains strongly positive, up about 46%.

What Drove the Recent Decline in CRS Shares

The central catalyst was the fiscal Q4 2026 earnings report released on July 30. Carpenter delivered record quarterly operating income of $206.9 million, up 11% sequentially, and an SAO adjusted operating margin of 37.8%, its 18th consecutive quarter of expansion, while EPS of $3.23 topped the $3.08 consensus estimate. However, revenue of $851.0 million came in below the $863.3 million consensus, and shares fell in premarket trading as investors weighed the top-line miss against an already rich valuation of roughly 45 to 48 times trailing earnings. Because the stock had rallied sharply into the report, even a modest shortfall triggered profit-taking. In August, the board authorized a new $1.0 billion share-repurchase program after exhausting the prior $400 million authorization, and several analysts raised price targets, including TD Cowen to $650 and BTIG to $620, while Wells Fargo lifted its target to $540. Those supportive developments did not halt the slide. Insider activity also drew attention: Chief Executive Officer Tony Thene sold shares in late August, and aggregate insider selling over the prior 12 months had exceeded $40 million. Combined with broader equity-market volatility and rotation out of higher-multiple industrial and materials names, these factors outweighed the company's positive fundamental news during the period. From what I see, the valuation reset played a larger role than any fundamental shift.

Quarterly Performance Context and Forward Guidance

Over the trailing three months, the larger narrative has been a pullback from peak valuation rather than a deterioration in fundamentals. The fiscal Q4 report confirmed accelerating aerospace and defense demand, with A&D sales up 17% year over year, and management issued fiscal 2027 operating income guidance of $850 million to $880 million, implying growth of 21% to 25% from fiscal 2026's record $702 million. The stock, however, had already priced in much of that strength after a multi-year rally, leaving it vulnerable once the revenue miss and cautious commentary about structural-customer ordering patterns reset expectations. The quarterly decline therefore reflects a market re-rating of a stock trading near peak multiples, even as the underlying demand environment remained robust.

Key Factors to Watch for CRS Going Forward

Investors will be watching whether Carpenter can execute against its fiscal 2027 guidance when it next reports earnings, currently estimated for late October 2026. The company guided first-quarter fiscal 2027 operating income to $195 million to $200 million, and any deviation could move the stock given its elevated multiple. Demand trends in the aerospace supply chain remain key, including production-rate increases from Boeing (BA) and engine demand tied to RTX (RTX) and other manufacturers. Progress on the Athens, Alabama brownfield expansion, which is expected to begin commissioning in early fiscal 2028, is another important variable. Finally, valuation re-rating risk, margin sustainability in the SAO segment, macroeconomic conditions, and trade or tariff policy remain factors that could influence the stock's direction. I’m watching this closely as earnings season approaches.

Using Tickeron’s AI Tools in My Research

I’ve found Tickeron’s AI Trading Bots helpful for testing automated strategies across different market conditions. The platform offers a range of bots with varying holding periods and risk profiles, which lets me compare approaches that align with my own style. I check the Trending AI Robots page regularly to see which strategies are showing momentum right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CRS in downward trend: price dove below 50-day moving average on August 10, 2026

CRS moved below its 50-day moving average on August 10, 2026 date and that indicates a change from an upward trend to a downward trend. In of 38 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRS as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for CRS crossed bearishly below the 50-day moving average on August 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CRS entered a downward trend on September 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CRS's RSI Oscillator exited the oversold zone, of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRS advanced for three days, in of 348 cases, the price rose further within the following month. The odds of a continued upward trend are .

CRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CRS's P/B Ratio (10.204) is slightly higher than the industry average of (3.382). P/E Ratio (43.579) is within average values for comparable stocks, (31.846). CRS's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (0.885). Dividend Yield (0.002) settles around the average of (0.020) among similar stocks. P/S Ratio (7.396) is also within normal values, averaging (5901.187).

Industry description

The industry is involved in value-added processes including creation of metal structures like machines and parts by cutting, bending and assembling, using various raw materials. A fabrication shop often bids on a project/job, and then builds the product if awarded the contract. Robotics and automation are making their way into the industry apparently to fill in skills gap[s19] . RBC Bearings Incorporated, Timken Company and Valmont Industries, Inc. are some of the largest metal fabrication companies in the U.S.

Market Cap

The average market capitalization across the Metal Fabrication Industry is 4.93B. The market cap for tickers in the group ranges from 723 to 56.71B. MEKTF holds the highest valuation in this group at 56.71B. The lowest valued company is BDGY at 723.

High and low price notable news

The average weekly price growth across all stocks in the Metal Fabrication Industry was -0%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was 9%. TRSG experienced the highest price growth at 8%, while OLOX experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Metal Fabrication Industry was -29%. For the same stocks of the Industry, the average monthly volume growth was -76% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 49
P/E Growth Rating: 55
Price Growth Rating: 56
SMR Rating: 76
Profit Risk Rating: 73
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
CRS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of specialty metals

Industry MetalFabrication

Profile
Details
Industry
Metal Fabrication
Address
1735 Market Street
Phone
+1 610 208-2000
Employees
4500
Web
https://www.carpentertechnology.com
Interact to see
Advertisement
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.
Shares of Red Cat Holdings surged approximately +22% in early Friday trading on March 6, 2026, building on a powerful week of momentum in defense drone stocks. The primary catalyst is escalating geopolitical conflict — U.S. and Israeli military strikes on Iran, which dramatically boosted investor appetite for domestic drone and defense technology companies.
The primary catalyst for the decline was the pricing of a secondary offering of roughly 9 million shares at about 22.25 dollars per share by Ingram Holdco, an affiliate of Platinum Equity, with all proceeds going to the selling shareholder and not to Ingram Micro itself. Investors often view such secondary offerings as short‑term bearish because they increase the freely tradable float and signal that a major holder is cashing out part of its stake, even if the company’s operations remain intact.
Rumble reported Q4 2025 revenue of about 27.1 million dollars, below consensus expectations near 29 million dollars and down roughly 10% year over year, confirming that top‑line momentum has stalled. GAAP EPS came in at a loss of around 0.13 dollars, missing analyst estimates by roughly 0.05 dollars and underscoring that the platform remains far from break‑even despite prior cost cuts and efficiency efforts.
Tronox’s Q4 2025 non‑GAAP EPS came in at a loss of about 0.60 dollars, missing expectations by roughly 0.02 dollars, while revenue of around 730 million dollars grew about 8% year over year, showing volume resilience but weak earnings power.
Defense budgets worldwide are surging — global military spending topped $2.2 trillion in 2023, a record high — while semiconductor demand is projected to reach a $1 trillion industry by 2030. At the intersection of these two mega-trends sits one of Tickeron's most strategically focused AI Trading Robots: the XAR, ITA, SOXL – AI Trading Agent (3 Tickers), 15min.
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.